{
    "title": "113_hr1239",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Accessing Medicare Therapies Act of \n2013''.\n\nSEC. 2. COUNTING THE NEGOTIATED PRICE OF DRUGS PROVIDED FREE OR AT \n              NOMINAL CHARGE UNDER COMPASSIONATE TREATMENT PROGRAMS \n              TOWARDS INCURRED OUT-OF-POCKET COSTS.\n\n    (a) In General.--Section 1860D-2(b)(4) of the Social Security Act \n(42 U.S.C. 1395w-102(b)(4)) is amended--\n            (1) in subparagraph (C), by striking ``subparagraph (E)'' \n        and inserting ``subparagraphs (E) and (F)''; and\n            (2) by adding at the end the following new subparagraph:\n                    ``(F) Inclusion of negotiated price of drugs \n                provided under compassionate treatment programs.--\n                            ``(i) In general.--In applying subparagraph \n                        (A) with respect to an individual enrolled in a \n                        prescription drug plan, incurred costs shall \n                        include the negotiated price described in \n                        clause (ii) of a covered part D drug if--\n                                    ``(I) the drug is classified, for \n                                purposes of applying tiered copayments \n                                consistent with section 1860D-\n                                2(b)(2)(B), in the highest copayment \n                                tier (such as a tier 4 for specialty \n                                brand-name drugs);\n                                    ``(II) the drug is furnished to the \n                                individual free or at nominal charge \n                                under a compassionate treatment program \n                                (as defined in clause (iii)); and\n                                    ``(III) the drug, if furnished \n                                other than through such program, is \n                                covered under the formulary of the plan \n                                or is available through exception or \n                                appeal.\n                            ``(ii) Negotiated price.--The negotiated \n                        price described in this clause, for a covered \n                        part D drug which is dispensed to an enrollee--\n                                    ``(I) by a pharmacy, is the \n                                negotiated price at such pharmacy; or\n                                    ``(II) other than by a pharmacy, is \n                                the average negotiated price for the \n                                drug in the prescription drug plan in \n                                the zip code of the enrollee as of the \n                                date the drug is dispensed.\n                            ``(iii) Compassionate treatment program \n                        defined.--In this subparagraph, the term \n                        `compassionate treatment program' means, with \n                        respect to covered part D drugs, a program \n                        that--\n                                    ``(I) is administered by an entity \n                                described in section 501(c)(3) of the \n                                Internal Revenue Code of 1986 that is \n                                exempt from tax under section 501(a) of \n                                such Code;\n                                    ``(II) takes title to the drugs and \n                                distributes the drugs to eligible part \n                                D individuals free or at nominal charge \n                                on the basis of the entity's assessment \n                                of financial need of such individuals;\n                                    ``(III) does not distribute the \n                                drugs to an individual unless the \n                                individual's household income (as \n                                determined under section 36B of the \n                                Internal Revenue Code of 1986) is less \n                                than the maximum income level for the \n                                taxpayer in the household to be \n                                eligible for a refundable credit under \n                                such section; and\n                                    ``(IV) meets such additional \n                                requirements as the Inspector General \n                                of the Department of Health and Human \n                                Services establishes, consistent with \n                                guidance and advisory opinions issued \n                                under section 1128D, to prevent fraud \n                                or abuse in the application of this \n                                subparagraph.''.\n    (b) Effective Date.--The amendments made by subsection (a) shall \napply to drugs furnished in plan years beginning on or after January 1, \n2014."
}